The agency’s new guidelines are created to eliminate pharmaceutical company practices that minimize or distract consumers ...
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
FDA's Orange Book: Iterum has submitted patent information for four U.S. patents for ORLYNVAH TM that will be listed in FDA's Orange Book: Approved Drug Products with Therapeutic Equivalence ...
The Company currently has 12 listed patents for IGALMI in the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) with expiration dates between 2037 and 2043. Recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback